Atención médica de calidadDescubra por qué Mayo Clinic es el mejor lugar para atenderse. Pide una cita.
James F. Meschia, M.D., is a neurology researcher who studies stroke. Dr. Meschia's main research interests and goals are to use biochemical and molecular genetic techniques to advance the development of biomarkers to assess risk of stroke and related stroke injury and to identify new drug targets for stroke therapies. Dr. Meschia also leads multicenter randomized clinical trials to advance evidence-based medicine.
About 10% of patients with acute stroke have preexisting dementia, and about 20% will develop dementia within 1 to 2 years after a stroke. Dr. Meschia's research is helping discover blood and imaging biomarkers to create better tools to predict who is at risk of stroke and to develop molecular targets for novel therapies to reduce the risk of cognitive impairment. Currently, the only medical intervention is to focus on preventing recurrent stroke. Ideally, biomarkers for cognitive impairment could be assessed in the acute or subacute period after stroke so that interventions could be initiated to prevent post-stroke dementia.
Infórmate sobre los ensayos clínicos que abordan preguntas científicas específicas sobre la salud humana y las enfermedades.
Ver mis estudios.
Explora todos los estudios de investigación en Mayo Clinic.
Ver las conclusiones revisadas por colegas que publiqué como resultado de mi investigación.